JP2022529743A5 - - Google Patents
Info
- Publication number
- JP2022529743A5 JP2022529743A5 JP2021563213A JP2021563213A JP2022529743A5 JP 2022529743 A5 JP2022529743 A5 JP 2022529743A5 JP 2021563213 A JP2021563213 A JP 2021563213A JP 2021563213 A JP2021563213 A JP 2021563213A JP 2022529743 A5 JP2022529743 A5 JP 2022529743A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120173A JP2025157413A (ja) | 2019-04-24 | 2025-07-17 | 自己免疫疾患を治療するための抗ｃｄ１９抗体の使用 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838093P | 2019-04-24 | 2019-04-24 | |
| US62/838,093 | 2019-04-24 | ||
| US201962843096P | 2019-05-03 | 2019-05-03 | |
| US62/843,096 | 2019-05-03 | ||
| US201962858495P | 2019-06-07 | 2019-06-07 | |
| US62/858,495 | 2019-06-07 | ||
| PCT/US2020/029613 WO2020219743A2 (en) | 2019-04-24 | 2020-04-23 | Use of an anti-cd19 antibody to treat autoimmune disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120173A Division JP2025157413A (ja) | 2019-04-24 | 2025-07-17 | 自己免疫疾患を治療するための抗ｃｄ１９抗体の使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022529743A JP2022529743A (ja) | 2022-06-23 |
| JPWO2020219743A5 JPWO2020219743A5 (https=) | 2023-09-14 |
| JP2022529743A5 true JP2022529743A5 (https=) | 2023-09-14 |
| JP7779738B2 JP7779738B2 (ja) | 2025-12-03 |
Family
ID=72940915
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563213A Active JP7779738B2 (ja) | 2019-04-24 | 2020-04-23 | 自己免疫疾患を治療するための抗ｃｄ１９抗体の使用 |
| JP2025120173A Pending JP2025157413A (ja) | 2019-04-24 | 2025-07-17 | 自己免疫疾患を治療するための抗ｃｄ１９抗体の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120173A Pending JP2025157413A (ja) | 2019-04-24 | 2025-07-17 | 自己免疫疾患を治療するための抗ｃｄ１９抗体の使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220204617A1 (https=) |
| EP (1) | EP3959241A4 (https=) |
| JP (2) | JP7779738B2 (https=) |
| KR (1) | KR20220004113A (https=) |
| CN (1) | CN113939532A (https=) |
| AU (1) | AU2020263418A1 (https=) |
| BR (1) | BR112021020924A2 (https=) |
| CA (1) | CA3136487A1 (https=) |
| IL (1) | IL287385A (https=) |
| MX (1) | MX2021012870A (https=) |
| SG (1) | SG11202111429UA (https=) |
| WO (1) | WO2020219743A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3809260A1 (de) * | 2019-10-18 | 2021-04-21 | Siemens Healthcare GmbH | System und verfahren zur administration von bildgebenden geräten |
| JP2023534916A (ja) * | 2020-06-30 | 2023-08-15 | ビエラ バイオ インコーポレイテッド | 視神経脊髄炎スペクトラム障害を治療する方法 |
| JP2023549075A (ja) * | 2020-10-29 | 2023-11-22 | ビエラ バイオ インコーポレイテッド | 自己免疫疾患を治療するための抗ｃｄ１９抗体の使用 |
| IL308296A (en) * | 2021-05-07 | 2024-01-01 | Viela Bio Inc | Use of anti-CD19 antibody to treat myasthenia gravis |
| KR20250044695A (ko) | 2022-07-27 | 2025-04-01 | 비엘라 바이오, 인크. | 이네빌리주맙 및 지속적인 b-세포 고갈을 위한 이의 사용 방법 |
| WO2024155810A1 (en) * | 2023-01-20 | 2024-07-25 | Viela Bio, Inc. | Anti-cd19 binding agents for the treatment and prevention of immune mediated necrotizing myopathy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101456728B1 (ko) * | 2006-09-08 | 2014-10-31 | 메디뮨 엘엘씨 | 인간화 항-ｃｄ19 항체, 및 이것의 종양학, 이식 및 자가면역 질환의 치료에서의 용도 |
| SI2066349T1 (sl) * | 2006-09-08 | 2012-08-31 | Medimmune Llc | Humanizirana anti-cd19 protitelesa in njihova uporaba v zdravljenju tumorjev, transplantacijah in avtoimunih boleznih |
| MX2011009312A (es) * | 2009-03-06 | 2012-02-29 | Medimmune Llc | Formulaciones de anticuerpos humanizados anti-cd19. |
| CN104640560A (zh) * | 2012-03-12 | 2015-05-20 | 米迪缪尼有限公司 | 用抗-cd19抗体治疗多发性硬化症 |
| GB201401465D0 (en) * | 2014-01-29 | 2014-03-12 | Roach Arthur H | Use of cladribine for treating autoimmune inflammatory disease |
-
2020
- 2020-04-23 MX MX2021012870A patent/MX2021012870A/es unknown
- 2020-04-23 CN CN202080030819.6A patent/CN113939532A/zh active Pending
- 2020-04-23 WO PCT/US2020/029613 patent/WO2020219743A2/en not_active Ceased
- 2020-04-23 CA CA3136487A patent/CA3136487A1/en active Pending
- 2020-04-23 JP JP2021563213A patent/JP7779738B2/ja active Active
- 2020-04-23 EP EP20794203.8A patent/EP3959241A4/en active Pending
- 2020-04-23 BR BR112021020924A patent/BR112021020924A2/pt unknown
- 2020-04-23 KR KR1020217038068A patent/KR20220004113A/ko active Pending
- 2020-04-23 SG SG11202111429UA patent/SG11202111429UA/en unknown
- 2020-04-23 AU AU2020263418A patent/AU2020263418A1/en active Pending
- 2020-04-23 US US17/606,306 patent/US20220204617A1/en active Pending
-
2021
- 2021-10-19 IL IL287385A patent/IL287385A/en unknown
-
2025
- 2025-07-17 JP JP2025120173A patent/JP2025157413A/ja active Pending